JNJ

Johnson & Johnson JNJ

$253.04 +3.07 (+1.23%)

Neutral · +0.38σ

+ Compare Open in Sniper

Mkt cap $609.2B

P/E 30.0

Day $251.95 – $255.66

52wk $210.50 – $269.43

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

Johnson & Johnson is a healthcare company listed in the US.

JNJ last traded at $253.04, up 1.2% on the day; that's in the upper part of its 52-week range ($210.50–$269.43). Right now it's trading close to its recent average, with no strong stretch in either direction.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and day to day, watch whether it holds above or slips below its recent average.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $107.83 (fair range $104–$157); today's price sits 140% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Intrinsic (DCF)

$107.83

Fair-value range

$103.95 – $157.43

Margin of safety

-140%

Verdict

Overvalued

Accounting quality Weak

✓ Gross margin 68% (pricing power)
✓ Net margin 22%

⚠ Debt exceeds cash
⚠ Quick ratio 0.72 (fragile)
⚠ Receivables growing faster than revenue
⚠ Inventory growing faster than revenue

Price implies ~24% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

JNJ is a $609.2 billion company, priced at 30× last year's earnings.

Mkt cap $609.2B

P/E ttm 30.0

Fwd P/E —

Beta —

Day range $251.95 – $255.66

52w range $210.50 – $269.43

Avg vol —

RSI(2) 66.2

ROE —

Net mgn —

FCF mgn 13.3%

Debt/Eq 0.68

Div yld —

Sector Healthcare

Industry Drug Manufacturers - General

Next earn —

52-week range · today's price

$210.50$269.43